Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 231-509-8 | CAS number: 7601-54-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics in vivo
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- supporting study
- Reliability:
- 3 (not reliable)
- Rationale for reliability incl. deficiencies:
- other: Documentation insufficient for assessment
Data source
Reference
- Reference Type:
- publication
- Title:
- Renal damage following the ingestion of a diet containing an excess of inorganic phosphate.
- Author:
- MacKay EM, Oliver J
- Year:
- 1 935
- Bibliographic source:
- J Exp Med. 61(3):319-334, PMID: 19870361
Materials and methods
- Objective of study:
- distribution
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Female albino rats were fed different diets containing inorganic phosphate. After 44 days, the animals were killed and anatomical measurements were conducted. Kidneys, heart and liver were preserved and subjected to histopathological examination.
- GLP compliance:
- no
Test material
- Reference substance name:
- Disodium hydrogenorthophosphate
- EC Number:
- 231-448-7
- EC Name:
- Disodium hydrogenorthophosphate
- Cas Number:
- 7558-79-4
- Molecular formula:
- H3O4P.2Na
- IUPAC Name:
- disodium hydrogen phosphate
- Details on test material:
- - Name of test material (as cited in study report): Na2HPO4 (diet 4)
Constituent 1
- Radiolabelling:
- no
Test animals
- Species:
- rat
- Strain:
- other:
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Age at study initiation: 26 days
- Individual cages: no (4-6 rats/cage)
- Diet (e.g. ad libitum): specified in Table 1
Administration / exposure
- Route of administration:
- oral: feed
- Vehicle:
- unchanged (no vehicle)
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
Inorganic phosphates were mixed in the feed - Duration and frequency of treatment / exposure:
- 44 days, no data on food amount/day was provided
- No. of animals per sex per dose / concentration:
- 18-25 rats/diet
- Control animals:
- yes, concurrent vehicle
Results and discussion
- Preliminary studies:
- not performed
Toxicokinetic / pharmacokinetic studies
- Details on absorption:
- not examined
- Details on distribution in tissues:
- The mean results of the anatomical measurements made at death comprise Table 3. From these it is evident that the addition of an excess of inorganic phosphate in any form to the diet leads to a tremendous increase in the weight of the kidneys. They are likewise much larger in size than the controls. The variation in the phosphate intake had no constant effect (Table 3) upon the weight of the heart or the liver.
From the results summarized in Table 4 it is seen that there is no constant relationship between the phosphate intake and the increase in renal weight. Neither is there a consistent difference in the effect of various types of phosphate. It is evident, however, that there is a general tendency for the increase in the weight of the kidneys to keep pace with the increasing phosphate intake.
The gross appearance of all of the phosphate kidneys was unusual. Their capsules always stripped readily and the color was then ordinarily more of a greyish white than the normal red-brown, particularly after the blood had been drained from the organ. In some of the experiments most of the kidneys had a smooth but mottled surface while in others the majority were coarsely granular or even pebbled in appearance. The cortical surfaces were most granular in Experiment 4 but also very noticeably so in Experiment 3, and less so in No. 5. The kidneys from all of the phosphate-fed animals felt very much firmer than normal and on section the cortex and medulla stood out clearly, particularly the outer stripe of the outer zone of the medulla.
Microscopical examination showed essentially the same lesion in all the kidneys, irrespective of the nature of the phosphate used in the experiment. No abnormalities were found in sections of the heart or liver. The kidneys of the control animals of all the experiments were entirely normal. The lesion consists of a complete disorganization of the outer stripe of the outer zone of the medulla.
In the kidneys of the phosphate-fed animals this section is transformed into a poorly outlined zone of distorted tubules that have lost all their normal characteristics. They are lined by a regenerated epithelium of markedly atypical appearance in which hyperplasia of the component cells is so extreme that giant cell-like masses may occlude the lumen. If an irregular lumen persists it is commonly filled with debris and masses of calcareous material. Other tubules are greatly dilated and at least in part are packed with calcium deposits. About the distorted cross-sections of the tubules may be seen round cell infiltration and some fibrosis.
The cortex is also involved to a greater or less degree in all the kidneys. The lesion in this part of the kidney appears to be an extension upward from the more severely involved outer stripe of the medulla and consists of either cystic dilatation of tubules or collapse of them associated with more or less round cell infiltration in the interstitial tissue. If such areas reach the free surface of the organ a retracted scar results.
- Details on excretion:
- not examined
Metabolite characterisation studies
- Metabolites identified:
- not measured
- Details on metabolites:
- not measured
Any other information on results incl. tables
Table 3: Group means of anatomical measurements made at dead (day 44 of treatment)
Experiment No. |
1 |
3 |
4 |
5 |
Form of added phosphate |
- (control) |
NaH2PO4 |
Na2HPO4 |
Na3PO4 |
No. of rats in experiment |
25 |
24 |
18 |
22 |
Body weight (gross) [g] |
135 |
132 |
111 |
130 |
Body surface [cm3] |
290 |
284 |
261 |
285 |
Heart weight [mg] |
501 |
516 |
446 |
493 |
Heart weight/100 cm³ body surface [mg] |
173 |
182 |
178 |
173 |
Liver weight [g] |
5.02 |
6.10 |
5.64 |
5.06 |
Liver weight/100 cm³ body surface [g] |
2.11 |
2.23 |
2.26 |
1.77 |
Kidney weight (average) [mg] |
449 |
848 |
858 |
794 |
Kidney weight/100g body weight [mg] |
337 |
678 |
834 |
631 |
Kidney weight/100 cm³ body surface [mg] |
154 |
291 |
342 |
278 |
Table 4: Food intake and kidney weight, group averages
No. |
Form of added phosphate |
Intake per 100 cm³ body surface/day |
Kidney per 100 cm³ body surface |
Phosphate above control |
||
Food [g] |
Phosphate [m.-eq.] |
Total [mg] |
Above control [mg] |
|||
1 |
- (control) |
3.06 |
0.61 |
154 |
|
|
3 |
NaH2PO4 |
3.54 |
5.60 |
291 |
135 |
5.01 |
4 |
Na2HPO4 |
2.83 |
4.47 |
342 |
186 |
3.88 |
5 |
Na3PO4 |
3.17 |
3.49 |
278 |
122 |
2.90 |
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): bioaccumulation potential cannot be judged based on study results
The addition of an excess of inorganic phosphate in any form to the diet leads to a tremendous increase in the weight of the kidneys, which are much larger in size than the controls, but not of liver or heart. Furthermore, excess phosphate uptake leads to necrosis of the terminal portion of the proximal convolution in the nephrons and to deposition of calcium salts in the necrotic debris that fills the involved tubules. - Executive summary:
Female rats were fed with different sodium phosphate salts (including phosphate, hydrogenorthophosphate and dihydrogenorthophosphate) for 44 days. Subsequently, the animals were killed, anatomical measurements were performed and kidneys, heart and liver were preserved and subjected to histopathological examination. For the whole methodological procedure, the authors referred to another publication which is not available to date (MacKay LL, MacKay EM, Am. J. Physiol., 1927, 83: 179). The amount of phosphate in the diet was only given in the unusual unit of milli-equivalents which (without knowledge of the food consumption of the animals) cannot be converted to daily doses. Nearly all anatomical parameters are normalized on the mean body surface of the animals which is not an accurate measure as the skin of the animals is flexible to a certain degree.
The results make evident that the addition of an excess of inorganic phosphate in any form to the diet leads to a tremendous increase in the weight of the kidneys, which are much larger in size than the controls. The variation in the phosphate intake had no effect upon the weight of the heart or the liver.
The gross appearance of the kidneys of the rats treated with phosphate was markedly different from the control animals’ kidneys.
Microscopical examination showed essentially the same lesion in all the kidneys, irrespective of the nature of the phosphate used in the experiment. No abnormalities were found in sections of the heart or liver. The kidneys of the control animals of all the experiments were entirely normal. The lesion consists of a complete disorganization of the outer stripe of the outer zone of the medulla and in part also of the cortex.
Taken together, the repeated uptake of phosphate salts in any form leads to increase of the kidneys accompanied with marked changes in macroscopic and microscopic appearance which is due to definite necrosis of the terminal portion of the proximal convolution, just at the point where the broad proximal tubulus abruptly decreases in diameter to form the narrow limb of Henle’s loop and to deposition of calcium salts in the necrotic debris that fills the involved tubules.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
